Individuals with cardiovascular disease experienced greater severity of COVID-19 illness and longer recovery times in the presence of poor oral health, according to new research out of Egypt. In the study of 86 patients with cardiovascular…

MouthWatch, a leader in innovative teledentistry solutions, digital case presentation tools and intraoral cameras, will debut its MouthWatch Plus+ HD intraoral camera during SmileCon 2021 in Las Vegas. With a launch special price of $999…

Pfizer has applied for Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) to administer its COVID-19 vaccination to children ages 5 to 11. The FDA has already granted full approval to the Pfizer…

A patient asked me recently, “why should I have my treatment done here instead of a practice on my insurance plan? It costs me more.” That’s a loaded question, particularly when it comes at the end of the appointment. Fortunately, that’s…

United States pharmaceutical giant Johnson & Johnson (J&J) has requested approval from the US Food and Drug Administration (FDA) to allow booster shots of its one-dose COVID-19 to be administered to millions of Americans. J&J’s…

A new study recently published in the Lancet found that the effectiveness of the Pfizer vaccine to fight COVID-19 infection drops significantly after 6 months. Following administration of the second dose of the two-shot series, the efficacy…

Mortality rates for rural Americans are twice as high as Americans living in urban areas. According to the Kaiser Family Foundation, one in 434 rural Americans is dead due to infection with SARS-CoV-2. This rate is one in 513 for urban…

Strategic fit for Sun Life in attractive dental segments, more than doubling its U.S. employee benefits revenues and complementing its existing portfolio as a leader in health and group benefits Positions Sun Life as a leading dental…

While the United States’ public health focus has been strictly on the importance of getting vaccinated against COVID-19, the flu shot remains an important tool in efforts to support the health of all Americans. The COVID-19 pandemic has had…

The American pharmaceutical company, Merck, announced its medication, molnupiravir, decreased hospitalizations and deaths by 50% among individuals with COVID-19. The pill, which is taken twice daily for 5 days, would be the first…